"Our practice focuses on the treatment of patients with internal radiation therapy, termed 'Radiopharmaceutical Therapy' (RPT), primarily in the setting of oncologic disease. As a board certified nuclear medicine physician, I offer a safe and comfortable environment in the outpatient setting to receive specialized current and emerging RPT therapies. Current indications we treat are thyroid cancer, metastatic prostate cancer, lymphoma and metastatic neuroendocrine cancer. We work in close collaboration to coordinate your care together with your oncologist, endocrinologist, urologist or other referring provider."

During the past decade, Advanced Molecular Imaging and Therapy conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Molecular Imaging and Therapy" #1 collaborator was "PSI CRO" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Molecular Imaging and Therapy" are "Biochemical Recurrence of Malignant Neoplasm of Prostate" (1 trials), "Carcinoid" (1 trials), "Carcinoid Tumor" (1 trials), "GEP-NET" (1 trials) and "Gastroenteropancreatic Neuroendocrine Tumor" (1 trials). Many other conditions were trialed in "Advanced Molecular Imaging and Therapy" in a lesser frequency.

Most popular intervention types in "Advanced Molecular Imaging and Therapy" are "Drug" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "177Lu-rhPSMA-10.1 injection" (1 trials), "18F-rhPSMA-7.3 injection" (1 trials), "64Cu-SAR-BBN" (1 trials), "Everolimus 10 mg" (1 trials) and "Lanreotide 120Mg Sa Susp Inj Syringe" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Molecular Imaging and Therapy" are 2 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Advanced Molecular Imaging and Therapy". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Advanced Molecular Imaging and Therapy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Molecular Imaging and Therapy, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".